Verrica Pharmaceuticals Inc. Business Finance Contracts & Agreements
29 Contracts & Agreements
- Credit Agreements (6 contracts)
- Investor Rights Agreements (1)
- Loan Agreements (6)
- Release Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (5)
- Warrant Agreements (5)
- Form of Series B Warrant (Filed With SEC on November 21, 2024)
- Form of Series A Warrant (Filed With SEC on November 21, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on November 21, 2024)
- Underwriting Agreement, dated November 20, 2024, by and between the Company and Jefferies LLC (Filed With SEC on November 21, 2024)
- Fifth Amendment to Credit Agreement, dated as of August 2, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on November 5, 2024)
- Form of Stock Option Grant Notice and Stock Option Agreement under 2024 Inducement Plan (Filed With SEC on November 4, 2024)
- Form of Restricted Stock Unit Award Grant Notice and Award Agreement under 2024 Inducement Plan (Filed With SEC on November 4, 2024)
- Release Agreement, dated November 4, 2024, by and between the Company and Ted White (Filed With SEC on November 4, 2024)
- Fifth Amendment to Credit Agreement, dated as of August 2, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on August 14, 2024)
- Fourth Amendment to Credit Agreement, dated as of June 26, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on August 14, 2024)
- Third Amendment to Credit Agreement, dated as of May 6, 2024, by and between the Registrant and OrbiMed Royalty & Credit Opportunities IV, LP (Filed With SEC on August 14, 2024)
- Warrant to Purchase Common Stock, dated as of May 14, 2024, by and between the Registrant and Torii Pharmaceuticals Co., Ltd (Filed With SEC on August 14, 2024)
- Second Amendment to Credit Agreement, dated as of January 31, 2024, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP (Filed With SEC on February 29, 2024)
- First Amendment to Credit Agreement, dated as of December 20, 2023, by and between the Registrant and Orbimed Royalty & Credit Opportunities IV, LP (Filed With SEC on February 29, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 21, 2023)
- Underwriting Agreement, dated February 21, 2023, by and between the Company and Jefferies LLC (Filed With SEC on February 21, 2023)
- Underwriting Agreement by and between Verrica Pharmaceuticals Inc. and RBC Capital Markets, LLC, dated June 29, 2022 (Filed With SEC on July 1, 2022)
- Waiver and Second Amendment to Loan and Security Agreement, dated as of March 1, 2022 (Filed With SEC on March 2, 2022)
- Waiver and Second Amendment to Mezzanine Loan and Security Agreement, dated as of March 1, 2022 (Filed With SEC on March 2, 2022)
- Underwriting Agreement by and among Verrica Pharmaceuticals Inc., Jefferies LLC, Cowen and Company, LLC and RBC Capital Markets, LLC, dated March 22, 2021 (Filed With SEC on March 23, 2021)
- First Amendment to Mezzanine Loan and Security Agreement, by and among the Company, Silicon Valley Bank and WestRiver Innovation Lending Fund VIII, L.P., dated as of October 26,... (Filed With SEC on March 17, 2021)
- First Amendment to Loan and Security Agreement, by and between the Company and Silicon Valley Bank, dated as of October 26, 2020 (Filed With SEC on March 17, 2021)
- Mezzanine Loan and Security Agreement, by and among the Company, Silicon Valley Bank and WestRiver Innovation Lending Fund VIII, L.P., dated as of March 10, 2020 (Filed With SEC on May 7, 2020)
- Loan and Security Agreement, by and between the Company and Silicon Valley Bank, dated as of March 10, 2020 (Filed With SEC on May 7, 2020)
- Description of Verrica Pharmaceuticals Inc. Common Stock (Filed With SEC on March 13, 2020)
- Form of Underwriting Agreement (Filed With SEC on June 5, 2018)
- Restricted Stock Purchase Agreement, by and between the Registrant and Glenn Oclassen, dated as of August 7, 2014, as amended on January 31, 2018 (Filed With SEC on May 22, 2018)
- Amended and Restated Restricted Stock Purchase Agreement, by and between the Registrant and Matthew Davidson, dated as of December 2, 2015 (Filed With SEC on May 22, 2018)
- Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated February 20, 2018 (Filed With SEC on May 22, 2018)
